Home / PFND : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does PFND make money? Does PFND have pricing power? What's the Earnings Whisper? Will PFND profit more as the business scales? What is PFND's management track record? Is PFND's current price justified?

Pathfinder Cell Therapy, Inc.

$0 +$0.00 (+0.00%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

Day Range

$0$0

Year Range

$0$0

Market Cap

66.72K

AVG Volume

467

Trailing/Forward PE

-0.04/-

PEG ratio

-0

Dividend Yield

Next Earnings Date

Primary Exchange

Other OTC

Revenue (USD) · TTM

PFND Revenue (USD) · TTM by quarter
Period	Revenue (USD) · TTM
15 Q3	0
15 Q2	0
15 Q1	0
14 Q4	0
14 Q3	0
14 Q2	8K
14 Q1	26K
13 Q4	54K
13 Q3	85K
13 Q2	97K

Net Income (USD) · TTM

PFND Net Income (USD) · TTM by quarter
Period	Net Income (USD) · TTM
15 Q3	-1.39M
15 Q2	-1.37M
15 Q1	-1.4M
14 Q4	-1.54M
14 Q3	-1.63M
14 Q2	-1.65M
14 Q1	-1.61M
13 Q4	-1.71M
13 Q3	-1.76M
13 Q2	-1.84M

Operating Income (USD) · TTM

PFND Operating Income (USD) · TTM by quarter
Period	Operating Income (USD) · TTM
15 Q3	-775K
15 Q2	-779K
15 Q1	-900K
14 Q4	-1.12M
14 Q3	-1.31M
14 Q2	-1.42M
14 Q1	-1.64M
13 Q4	-1.76M
13 Q3	-1.83M
13 Q2	-1.93M

EBITDA (USD) · TTM

PFND EBITDA (USD) · TTM by quarter
Period	EBITDA (USD) · TTM
15 Q3	-772K
15 Q2	-776K
15 Q1	-897K
14 Q4	-1.12M
14 Q3	-1.3M
14 Q2	-1.41M
14 Q1	-1.47M
13 Q4	-1.59M
13 Q3	-1.66M
13 Q2	-1.75M

Cash Flows (USD) · TTM

PFND Cash Flows (USD) · TTM by quarter
Period	Cash Flows (USD) · TTM
15 Q3	-579K
15 Q2	-629K
15 Q1	-853K
14 Q4	-963K
14 Q3	-1.17M
14 Q2	-1.32M
14 Q1	-1.6M
13 Q4	-1.6M
13 Q3	-1.84M
13 Q2	-1.68M

EPS (USD) · TTM

PFND EPS (USD) · TTM by quarter
Period	EPS (USD) · TTM
15 Q3	-0
15 Q2	-0
15 Q1	-0
14 Q4	-0
14 Q3	-0
14 Q2	-0
14 Q1	-0
13 Q4	-0
13 Q3	-0
13 Q2	-0

Expenses (USD) · TTM

PFND Expenses (USD) · TTM by quarter
Period	Expenses (USD) · TTM
15 Q3	775K
15 Q2	779K
15 Q1	900K
14 Q4	1.12M
14 Q3	1.3M
14 Q2	1.41M
14 Q1	1.48M
13 Q4	1.62M
13 Q3	1.72M
13 Q2	1.82M

Shares Outstanding · TTM

PFND Shares Outstanding · TTM by quarter
Period	Shares Outstanding · TTM
15 Q3	0
15 Q2	0
15 Q1	-1K
14 Q4	-2K
14 Q3	-2K
14 Q2	-4K
14 Q1	-4K
13 Q4	-5K
13 Q3	-7K
13 Q2	-8K

Free Cash Flow Yield

PFND Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-867.86%
Sep 26	-867.86%
Aug 26	-867.86%
Aug 26	-867.86%
Aug 26	-867.86%
Aug 26	-867.86%
Jul 26	-867.86%
Jul 26	-867.86%
Jul 26	-867.86%
Jul 26	-867.86%
Jul 26	-867.86%
Jun 26	-867.86%
Jun 26	-867.86%
Jun 26	-867.86%
Jun 26	-867.86%
May 26	-867.86%
May 26	-867.86%
May 26	-867.86%
May 26	-867.86%
May 26	-867.86%
Apr 26	-867.86%
Apr 26	-867.86%
Apr 26	-867.86%
Apr 26	-867.86%
Mar 26	-867.86%
Mar 26	-867.86%
Mar 26	-867.86%
Mar 26	-867.86%
Feb 26	-867.86%
Feb 26	-867.86%
Feb 26	-867.86%
Feb 26	-867.86%
Jan 26	-867.86%
Jan 26	-867.86%
Jan 26	-867.86%
Jan 26	-867.86%
Jan 26	-867.86%
Dec 25	-867.86%
Dec 25	-867.86%
Dec 25	-867.86%
Dec 25	-867.86%
Nov 25	-867.86%
Nov 25	-867.86%
Nov 25	-867.86%
Nov 25	-867.86%
Oct 25	-867.86%
Oct 25	-867.86%
Oct 25	-867.86%
Oct 25	-867.86%
Oct 25	-867.86%
Sep 25	-867.86%
Sep 25	-867.86%
Sep 25	-867.86%
Sep 25	-867.86%
Aug 25	-867.86%
Aug 25	-867.86%
Aug 25	-867.86%
Aug 25	-867.86%
Aug 25	-867.86%
Jul 25	-867.86%
Jul 25	-867.86%
Jul 25	-867.86%
Jul 25	-867.86%
Jun 25	-867.86%
Jun 25	-867.86%
Jun 25	-867.86%
Jun 25	-867.86%
May 25	-867.86%
May 25	-867.86%
May 25	-867.86%
May 25	-867.86%
May 25	-867.86%
Apr 25	-867.86%
Apr 25	-867.86%
Apr 25	-867.86%
Apr 25	-867.86%
Mar 25	-867.86%
Mar 25	-867.86%
Mar 25	-867.86%
Mar 25	-867.86%
Feb 25	-867.86%
Feb 25	-867.86%
Feb 25	-867.86%
Feb 25	-867.86%
Jan 25	-867.86%
Jan 25	-867.86%
Jan 25	-867.86%
Jan 25	-867.86%
Jan 25	-867.86%
Dec 24	-867.86%
Dec 24	-867.86%
Dec 24	-867.86%
Dec 24	-867.86%
Nov 24	-867.86%
Nov 24	-867.86%
Nov 24	-867.86%
Nov 24	-867.86%
Nov 24	-867.86%
Oct 24	-867.86%
Oct 24	-867.86%

Price to Sales

PFND Price to Sales by quarter
Period	Price to Sales
Dec 14	75.06
Dec 14	91.73
Dec 14	100.07
Dec 14	166.79
Nov 14	125.09
Nov 14	125.09
Nov 14	125.09
Nov 14	116.75
Oct 14	166.79
Oct 14	166.79
Oct 14	166.79
Oct 14	166.79
Oct 14	183.47
Sep 14	76.98
Sep 14	128.3
Sep 14	189.88
Sep 14	53.89
Aug 14	56.45
Aug 14	76.98
Aug 14	53.89
Aug 14	56.45
Aug 14	84.68
Jul 14	64.15
Jul 14	102.64
Jul 14	115.47
Jul 14	115.47
Jun 14	55.6
Jun 14	43.24
Jun 14	61.77
Jun 14	123.55
May 14	61.77
May 14	61.77
May 14	61.77
May 14	61.77
May 14	88.95
Apr 14	88.95
Apr 14	88.95
Apr 14	88.95
Apr 14	203.85
Mar 14	86.34
Mar 14	86.34
Mar 14	86.34
Mar 14	86.34
Feb 14	117.73
Feb 14	94.19
Feb 14	139.71
Feb 14	94.19
Jan 14	94.19
Jan 14	86.34
Jan 14	86.34
Jan 14	86.34
Jan 14	109.89
Dec 13	96.29
Dec 13	171.95
Dec 13	48.15
Dec 13	89.41
Nov 13	48.15
Nov 13	48.15
Nov 13	68.78
Nov 13	61.9
Nov 13	65.34
Oct 13	61.9
Oct 13	34.39
Oct 13	55.02
Oct 13	24.76
Sep 13	25.33
Sep 13	47.57
Sep 13	47.57
Sep 13	51.27
Aug 13	51.27
Aug 13	61.77
Aug 13	51.27
Aug 13	51.89
Aug 13	51.89
Jul 13	51.89
Jul 13	63.01
Jul 13	216.21
Jul 13	123.55
Jun 13	87.78
Jun 13	87.78
Jun 13	234.09
Jun 13	234.09
May 13	87.78
May 13	87.78
May 13	117.05
May 13	117.05
May 13	87.78
Apr 13	117.05
Apr 13	146.31
Apr 13	146.31
Apr 13	128.75
Mar 13	88.81
Mar 13	88.81
Mar 13	88.37
Mar 13	88.37
Mar 13	47.72
Feb 13	66.27
Feb 13	63.18
Feb 13	109.57
Feb 13	66.27

EV/EBITDA

PFND EV/EBITDA by quarter
Period	EV/EBITDA
Mar 13	2.7
Mar 13	2.7
Mar 13	2.69
Mar 13	2.69
Mar 13	1.59
Feb 13	2.09
Feb 13	2
Feb 13	3.26
Feb 13	2.09
Jan 13	2.69
Jan 13	1.97
Jan 13	2.69
Jan 13	3.28
Dec 12	3.68
Dec 12	5.19
Dec 12	3.35
Dec 12	2.12
Nov 12	4.52
Nov 12	3.68
Nov 12	2.85
Nov 12	3.68
Nov 12	4.52
Oct 12	2.85
Oct 12	2.85
Oct 12	2.85
Oct 12	2.85
Sep 12	4.52
Sep 12	4.42
Sep 12	3.59
Sep 12	4.42
Aug 12	4.58
Aug 12	4.58
Aug 12	6.9
Aug 12	3.75
Aug 12	3.25
Jul 12	5.25
Jul 12	5.25
Jul 12	4.09
Jul 12	3.75
Jun 12	6.58
Jun 12	4.85
Jun 12	4.85
Jun 12	4.05
Jun 12	4.05
May 12	4.05
May 12	4.85
May 12	4.05
May 12	6.46
Apr 12	6.46
Apr 12	6.46
Apr 12	6.46
Apr 12	6.46
Mar 12	8.06

Price to Book

PFND Price to Book by quarter
Period	Price to Book
Dec 10	44.73
Dec 10	39.47
Dec 10	39.47
Dec 10	46.05
Nov 10	39.47
Nov 10	52.63
Nov 10	59.21
Nov 10	59.21
Oct 10	68.42
Oct 10	78.94
Oct 10	65.79
Oct 10	65.79
Oct 10	52.63
Sep 10	8.67
Sep 10	6.93
Sep 10	6.93
Sep 10	12.14
Aug 10	9.53
Aug 10	11.27
Aug 10	11.27
Aug 10	13
Jul 10	11.79
Jul 10	10.4
Jul 10	15.6
Jul 10	13.87
Jul 10	14.74
Jun 10	12.5
Jun 10	15
Jun 10	10.63
Jun 10	10
May 10	16.25
May 10	11.88
May 10	10.63
May 10	10.25
Apr 10	11.25
Apr 10	17.5
Apr 10	12.5
Apr 10	12.5
Apr 10	16.25
Mar 10	14.26
Mar 10	14.26
Mar 10	12.22
Mar 10	10.18
Feb 10	13.6
Feb 10	13.6
Feb 10	12.22
Feb 10	12.32
Jan 10	18.33
Jan 10	13.14
Jan 10	13.24
Jan 10	15.79
Dec 09	20.37
Dec 09	18.73
Dec 09	18.73
Dec 09	14.05
Dec 09	18.73
Nov 09	16.76
Nov 09	14.98
Nov 09	18.73
Nov 09	22.47
Oct 09	13.11
Oct 09	27.16
Oct 09	21.54
Oct 09	22.47
Oct 09	28.09
Sep 09	10.16
Sep 09	9.68
Sep 09	10.64
Sep 09	11.61
Aug 09	11.61
Aug 09	9.19
Aug 09	11.61
Aug 09	12.1
Jul 09	10.16
Jul 09	11.61
Jul 09	10.64
Jul 09	9.68
Jul 09	9.68
Jun 09	6.81
Jun 09	7.83
Jun 09	9.19
Jun 09	10.21
May 09	9.53
May 09	8.51
May 09	10.55
May 09	9.19
May 09	11.57
Apr 09	12.59
Apr 09	11.23
Apr 09	11.91
Apr 09	12.93
Mar 09	7.03
Mar 09	8.08
Mar 09	7.49
Mar 09	2.11
Feb 09	2.58
Feb 09	2.34
Feb 09	3.28
Feb 09	3.51
Jan 09	3.4

No video analysis for this stock yet. Request one from our team.

News: PFND

defenseworld.net · 16 Aug 2026

Critical Analysis: Pathfinder Cell Therapy (OTCMKTS:PFND) and Nuvation Bio (NYSE:NUVB)

Nuvation Bio (NYSE: NUVB - Get Free Report) and Pathfinder Cell Therapy (OTCMKTS:PFND - Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation. Insider and Institutional Ownership 61.7% of Nuvation

AI Analysis

Pathfinder Cell Therapy, Inc.

Video analysis: PFND

News: PFND

Critical Analysis: Pathfinder Cell Therapy (OTCMKTS:PFND) and Nuvation Bio (NYSE:NUVB)

Similar companies